2018
DOI: 10.1002/hup.2682
|View full text |Cite
|
Sign up to set email alerts
|

The serotonin transporter and the activity regulated cytoskeleton‐associated protein genes in antidepressant response and resistance: 5‐HTTLPR and other variants

Abstract: Objective Previous evidence suggested the involvement of serotonin transporter (SLC6A4) and activity regulated cytoskeleton‐associated protein (ARC) in antidepressant action. This study investigated their role in antidepressant efficacy and treatment‐resistant depression (TRD). Methods Three samples (n total = 648) were investigated to test the association between treatment outcomes (response, remission, symptom improvement, and TRD) and 11 polymorphisms within SLC6A4 and ARC genes. The possible modulating eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 55 publications
1
4
1
Order By: Relevance
“…According to our main analyses, we did not find significant associations involving ARC polymorphisms with treatment outcomes in either of the investigated samples. Thus, we did not replicate our previous findings on rs10110456 and rs11167152 ARC SNPs [13]. We did detect some data indicating ARC polymorphisms being able to influence symptoms severity at baseline in both samples.…”
Section: Discussioncontrasting
confidence: 99%
See 3 more Smart Citations
“…According to our main analyses, we did not find significant associations involving ARC polymorphisms with treatment outcomes in either of the investigated samples. Thus, we did not replicate our previous findings on rs10110456 and rs11167152 ARC SNPs [13]. We did detect some data indicating ARC polymorphisms being able to influence symptoms severity at baseline in both samples.…”
Section: Discussioncontrasting
confidence: 99%
“…In this paper we focused on ARC possible influence on treatment efficacy and other clinical features in two samples of different ethnicity. The reason for this choice is based on previous research on possible associations of this gene with antidepressant efficacy (in particular with response and remission outcomes for rs10110456 and rs11167152) [13]. Unfortunately, despite the previous data, ARC variants do not seem to have any effect on treatment efficacy according to our principal data.…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…One of the most promising lines of research has focused on functional genetic variants in the human serotonin transporter gene (3). Thus, a long (L) variant of the upstream regulatory region of the 5HTT gene, conferring higher 5HTT activity compared to the short (S) variant, has been associated with better response to SSRI treatment in Caucasian populations (4,5). Additionally, lower DNA methylation levels in the 5HTT promoter region, associated with higher gene expression levels (6), were also found to predict better response to SSRI treatment (7).…”
Section: Introductionmentioning
confidence: 99%